Based on the CD93 expression profile within the tumour vasculature and its potential anti‐inflammatory roles, it is plausible to contemplate that CD93 may serve as an immunosuppressive molecule in the tumour microenvironment, limiting immune cell infiltration and facilitating tumour immune evasion mechanisms. This evidence concerns the gene CD93 and neoplasm.